MASTER Biotechnologies and Law - The legal treatment of new biological resources

This course is intended for two different categories of students from the first year of the master, i.e. those holding a degree in law or in sciences and those in pharmaceutical studies (5th year). This initial heterogeneity means that, during the first semester, students must acquire solid bases in the discipline that is complementary to their initial training through a teaching module (UE) that is specific to each type of public. All the other science, law and management/communication classes (modules 2 to 14) are studied by all students.
 
  • Aims
This course aims to train young graduates, who have already obtained dual skills, in the scientific and innovational concepts of biotechnologies and of the law that relates to the subject. As such, at the same time as reinforcing their initial discipline, students acquire complementary knowledge that enables them to play an essential role in working with biotechnology innovation management in development structures or as an interface in consultancy firms, investment funds, biotechnology companies and academic establishments.

The skills acquired during this course may be used to prepare patent applications, to draw up technology transmission agreements, to initiate business plans, to process approval procedures for innovative products and to manage the regulatory aspect of the biological and biotechnological activity. Priority is also given proficiency in law and biotechnology-related English, which is a prerequisite for integrating the professional world well.
 
  • Activity sectors
Major pharmaceutical groups and companies
Major agri-food product groups and companies (human and animal alimentation)
Businesses producing new varieties of plants (seed companies)
Investment funds dedicated to new technologies (venture capitalists)
Incubators in the field of biotechnologies
Legal and administrative departments of specialized public and private establishments (Institut Pasteur, Institut Curie, Institut Gustave Roussy (IGR), the National Institute of Health and Medical Research (INSERM), the National Centre for Scientific Research (CNRS), the National Institute for Agricultural Research (INRA), ANVAR – French Innovation Agency, the French Agency for the Safety of Health Products (AFSSAPS), the European Medicines Agency (EMEA), the French National Institute of Intellectual Property (INPI), the European Patent Office, etc.)
Assistance and financial support for development (OSEO)
Law firms specialized in business law
Industrial property consultancy firms
Human resources consultancy firms
 
  • Contents or list of themes and subjects taught
- Legal pre-course or introduction to biology and biotechnologies, based on students’ academic background
- Project management and communication
- English
- Tools for new biological resources
- Industrial property law and protection of inventions law
- Business taxation
- Applied communication management
- Biological tools for traceability
- The biotechnology company
- Legal tools for research and development
- Biotechnologies applied to human health
- Tools for entering professional life
 
  • Prerequisites
Students must hold a degree in biology or in life sciences or an equivalent, or be students in pharmaceutical studies (5th year), or hold a degree in law or an equivalent.